The World Affordable Medicine Congress Europe is the largest and most established strategy and scientific event on generic and biosimilar medicines. 

The benefits of generics and biosimilars are well celebrated and demand will remain strong as health systems grapple with escalating healthcare costs and austerity measures. However, the industry must continue to overcome barriers including the fluctuating policy environment, increasing competition, the innovator pipeline crisis and pricing pressure. In the rapidly changing market it is critical to adopt the right business strategy. 

The World Affordable Medicines Congress Europe brings together two world class events – World Generic Medicines Congress and Biosimilar Drug Development World – that have been central to the industry’s business and networking needs for over 10 years. 

This senior and board level executives will gather to hear a comprehensive review of business strategy for affordable medicines from leading organisations, fresh insights, policy updates, future market trends, innovative commercial strategies and opportunities for growth in the provision of generic and biosimilar drugs.

Over 2000 business leaders participants have benefited from this series since 2007!

Join them and be part of the story…